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Green tea is a popular drink, especially in Asian countries, although its popularity continues
to spread across the globe. The health benefits of green tea, derived from the leaves of
the Camellia sinensis plant, have been studied for many years. Fairly recently, researchers
have begun to look at the possibility of using green tea in antimicrobial therapy, and
the potential prevention of infections. The particular properties of catechins found in
the tea have shown promise for having antimicrobial effects. There are four main
catechins (polyphenols) found in green tea: (-)-epicatechin (EC), (-)-epicatechin-3-gallate
(ECG), (-)-epigallocatechin (EGC), and (-)-epigallocatechin-3-gallate (EGCG). Three of these,
ECG, EGC, and EGCG have been shown to have antimicrobial effects against a variety
of organisms. These catechins have exhibited a variety of antimicrobial mechanisms. The
results of studies on the antimicrobial effects of green tea have shown that the potential
for preventive and therapeutic purposes is present. Further data collection on studies
performed with human consumption during the course of infections, and studies on the
occurrence of infections in populations that consume regular amounts of green tea will
be necessary to complete the picture of its antimicrobial possibilities.
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INTRODUCTION
Tea is a very popular drink world-wide. It is produced from the plant Camellia sinensis, which is
grown in at least 30 countries, and grows best in certain tropical and subtropical regions (Gupta
et al., 2014). Tea is mainly produced as four varieties; white, green, Oolong, and black. White tea
is made from very young tea leaves or buds; green tea is made from mature unfermented leaves;
Oolong tea from partially fermented leaves; and black tea from fully fermented leaves (Jigisha et al.,
2012; Gupta et al., 2014). Most of the black tea produced is consumed in the United States, Oolong
tea is most popular in China and Taiwan, and green tea is most popular in China, Japan, and Korea
(Cabrera et al., 2006). Among the health benefits that have been studied using green tea are: as
an antioxidant, anti-inflammatory, anticarcinogenic, in cardiovascular health, oral health, and as
an antimicrobial. Antioxidant effects come from the ability of green tea to limit the amount of
free radicals by binding to reactive oxygen species (ROS) (Serafini et al., 2011; Jigisha et al., 2012;
Gupta et al., 2014). Anti-inflammatory effects may be a result of increased production of IL-10,
an anti-inflammatory cytokine. Inflammation is involved in, among other conditions, arthritis,
cardiovascular disease, aging, and cancer (Serafini et al., 2011; Jigisha et al., 2012). The anticar-
cinogenic effects of green tea have been seen in many types of cancer, and the mechanisms may
include inhibiting angiogenesis and cell growth, and inducing apoptosis in cancer cells (Serafini
et al., 2011; Jigisha et al., 2012; Subramani and Natesh, 2013). Cardiovascular effects include the
antioxidant and anti-inflammatory effects, and consumption of green tea has been shown to inhibit
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atherosclerosis, reduce lipid levels overall, and improve the ratio
of LDL to HDL (Serafini et al., 2011; Jigisha et al., 2012). The
effects for oral health are related to both teeth and gums. The
main cause of dental caries is the bacteria Streptococcus mutans.
Green tea has a direct antimicrobial effect on this bacteria,
plus it seems to inhibit the attachment of the bacteria to oral
surfaces. In addition, green tea is a natural source of fluoride
(Jigisha et al., 2012; Gupta et al., 2014). Green tea has been
shown to have antimicrobial effects against a variety of gram pos-
itive and gram negative bacteria (e.g., Escherichia coli, Salmonella
spp., Staphylococcus aureus, Enterococcus spp.), some fungi (e.g.,
Candida albicans), and a variety of viruses (e.g., HIV, herpes sim-
plex, influenza) (Jigisha et al., 2012; Steinmann et al., 2013). These
antimicrobial effects will be discussed in more detail later in this
paper.
KEY CONCEPT 1 | Antimicrobial
Antibacterial agents attack microorganisms through four main mechanisms:
inhibiting cell wall synthesis (β-lactams drugs, such as the penicillins
and cephalosporins), inhibiting protein synthesis (aminoglycosides, tetracy-
clines, etc.), inhibiting nucleic acid synthesis (fluoroquinolones), or inhibiting
metabolic pathways (trimethoprim, sulfonamides). Antiviral agents may tar-
get host cell entry, interfere with various stages of viral replication or
assembly, or interfere with virus release from the host cell. Since fungi
are eukaryotes, antifungal agents have to key in on differences between
human and fungal cell processes. Because the parasites are a widely diverse
group of organisms, antiparasitic agents are quite often specific for a certain
parasite or related parasite group (e.g., nematodes).
GREEN TEA COMPOSITION
The medically important components of green tea are the
polyphenols, most importantly the flavonoids. The main
flavonoids in tea are the catechins, making up 30–40% of the
water-soluble solids in green tea (Wang and Ho, 2009; Roowi
et al., 2010). The different types of tea vary in the amount of
catechins that they contain, with green tea containing the most,
then Oolong tea, then black tea. The initial steaming process in
the production of green tea destroys the enzyme polyphenol oxi-
dase, thus protecting the polyphenol content. There are four main
catechins in tea. (-)-epicatechin (EC), (-)-epicatechin-3-gallate
(ECG), (-)-epigallocatechin (EGC), and (-)-epigallocatechin-3-
gallate (EGCG). In green tea, EGCG is the most abundant,
representing approximately 59% of the total catechins. EGC is
next, making up approximately 19%. Then ECG, at 13.6%; and
EC, at 6.4% (Cabrera et al., 2006; Jigisha et al., 2012). In addi-
tion to the type of tea, the amount of catechins can be affected
by: where on the plant the leaves are harvested, leaf process-
ing, geographical location, growing conditions, and tea prepa-
ration (Fernandez et al., 2002; Lin et al., 2003; Cabrera et al.,
2006).
In order for any of the components of green tea to be a health
benefit they have to have bioavailability This is most commonly
assessed by measuring plasma, urine, and perhaps (in directed
studies) tissue levels of the components after ingestion; usually by
taking samples at regularly timed intervals. Various studies con-
ducted using consumption of green tea beverage (Henning et al.,
2004; Stalmach et al., 2009; Clifford et al., 2013), green tea extract
(Lee et al., 1995; Yang et al., 1998; Henning et al., 2004), or specific
catechins (Chow et al., 2001; Van Amelsvoort et al., 2001), have
shown that ECG, EGCG, and metabolites of EC and EGC can be
detected in blood plasma; and metabolites of EC and EGC only
can be detected in urine. The peak concentration in blood plasma
occurs at approximately 2 h after ingestion; and the peak concen-
tration in urine occurs approximately 4–6 h after consumption.
Some studies were performed using various dosages of the cate-
chins, and show that the bioavailability of the catechins is directly
proportional to the amount consumed (Nakagawa et al., 1997;
Yang et al., 1998; Chow et al., 2001, 2003; Ullmann et al., 2003).
Table 1 shows a summary of the results of these various bioavail-
ability studies, giving data specifically for EGCG and EGC. The
most abundant catechins in green tea, EGCG and EGC, also
occur in the greatest concentration in the body after consumption
(EGCG in plasma, and EGC in both plasma and urine).
KEY CONCEPT 2 | Bioavailability
Bioavailability is a measure of how much of a substance can be found in
blood, tissues, urine, etc., after being introduced into the body. Enough of
the substance must be present at the site of an infection in order to be
useful in fighting the microorganism(s) involved.
In a previous study (Reygaert and Jusufi, 2013), it was pro-
jected that using a brewed preparation of Japanese green tea
(containing approximately 20mg of EGC per gram of tea) would
result in approximately 150mg of ECG per cup of tea. The
amount of EGC excreted in the urine would be approximately
3.5mg per cup of tea.
ANTIMICROBIAL PROPERTIES OF GREEN TEA
In addition to the direct antimicrobial effects of catechins dis-
cussed below (damage to the bacterial cell membrane, inhibition
of fatty acid synthesis, inhibition of enzyme activity, etc.), there
are also some effects that may contribute to the total antimicro-
bial effect in infected individuals. These effects include inhibition
of inflammation (particularly inflammation caused by oxida-
tive stress, such as vascular), more specifically, by increasing
the synthesis of nitric oxide (Yamakuchi et al., 2008), inhibit-
ing angiotensin II and IL-6-induced C-reactive protein expression
(Li et al., 2012), suppression of IL-6 and RANKL production in
infected osteoblast-like cells (Ishida et al., 2007), inhibiting IL-
8 production (Hirao et al., 2010), and inhibiting hyaluronidase
activity (activated by chronic inflammation) by inhibition of
IL-12 (Adcocks et al., 2002).
DAMAGE TO THE BACTERIAL CELL MEMBRANE
Many of the direct effects of tea catechins are a result of the
catechins binding to the bacterial lipid bilayer cell membrane
which then causes damage to the membrane (Sirk et al., 2008,
2009). This damage can then lead to a variety of related antimi-
crobial effects. Researchers studying Escherichia coli found that
when exposed to green tea polyphenols, the bacterial response
was changed regulation of 17 individual genes. Nine genes were
upregulated and eight were downregulated. One of themajor out-
comes of this change in regulation was damage to the bacterial
cell membrane (Cho et al., 2007). Tea catechins have less effect
on gram negative bacterial cell membranes due to the fact that
the LPS outer membrane of gram negative bacteria is negatively
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Table 1 | Bioavailability of green tea catechins.
Catechin source Initial dose Plasma concentration (peak
time) EGCG, EGC
EGC in urine/24h
(peak time)
References
Green tea (bottled) EGCG 230μmol
EGC 257 μmol
EGCG ∼55 nmol/L (∼1.9 h)
EGC ∼205 nmol/L (∼2.2 h)
∼33μmol Clifford et al., 2013
Green tea (brewed) EGCG 214 mg
EGC 270mg
EGCG ∼80 nmol/L (∼1.3 h)
EGC ∼740 nmol/L (∼1.3 h)
ND Henning et al., 2004
Green tea extracts EGCG 193mg
EGC 25mg
EGCG ∼150 nmol/L (∼2.7 h)
EGC 110 nmol/L (∼2.6 h)
ND Henning et al., 2004
Green tea extracts EGCG 88mg
EGC 82mg
EGCG ∼135 ng/ml at 4 h
EGC ∼ 140 ng/ml at 1 h
∼3.0mg (3–6 h) Lee et al., 1995
Green tea (bottled) EGCG 235μmol
EGC 260μmol
EGCG ∼55 nM (∼1.9 h)
EGC ∼126 nM (∼2.2 h)
∼33μmol Stalmach et al., 2009
EGCG EGC EGCG 688mg
EGC 459mg
EGCG ∼1.3μmol (∼3.9 h)
EGC ∼5.0μmol (∼1.7 h)
ND Van Amelsvoort et al., 2001
Green tea extracts EGCG 110mg
EGC 102mg
EGCG ∼119 ng/ml (∼1.6 h)
EGC ∼148 ng/ml (∼1.4 h)
∼3000μg (4–6 h) Yang et al., 1998
charged (Ikigai et al., 1993). Bacterial cell membrane damage
inhibits the ability of the bacteria to bind to host cells (Sharma
et al., 2012), and inhibits the ability of the bacteria to bind to
each other to form biofilms, which are significant in pathogen-
esis (Blanco et al., 2005). Bacterial membrane damage also results
in an inability of the bacteria to be able to secrete toxins (Sugita-
Konishi et al., 1999; Shah et al., 2008). Directly related to the
homeostasis of the bacterial cell membrane is fatty acid synthesis.
INHIBITION OF FATTY ACID SYNTHESIS
Fatty acids in bacteria have important functions; as a component
of phospholipid cell membranes (and mycolic acid in cell walls
of mycobacteria), and as an excellent energy source. Researchers
have recently begun to look at the potential of targeting fatty acid
biosynthesis for antimicrobial drug development (Wang and Ma,
2013). Researchers have found that green tea components (espe-
cially EGCG) inhibit specific reductases (FabG, FabI) in bacterial
type II fatty acid synthesis (Zhang and Rock, 2004; Li et al., 2006).
Inhibition of fatty acid synthesis by green tea has also been found
to inhibit bacterial production of toxic metabolites (Sakanaka and
Okada, 2004).
INHIBITION OF OTHER ENZYME ACTIVITY
In addition to the enzymes involved in fatty acid synthesis,
research with green tea has been shown to have effects on other
essential bacterial enzymes. Researchers found that green tea
catechins have an inhibitory effect on protein tyrosine phos-
phatase and cysteine proteinases in certain anaerobic oral bacteria
(Okamoto et al., 2003, 2004). Researchers have also found that
green tea catechins have the ability to interfere with DNA repli-
cation by interacting with, and thereby inhibiting the function of
DNA gyrase (Grandišar et al., 2007). Studies on antifolate activ-
ity in microorganisms have shown that green tea polyphenols can
inhibit the enzyme dihydrofolate reductase in bacteria and yeast,
effectively blocking the ability of the microorganisms to synthe-
size folate (Navarro-Martinez et al., 2005, 2006). More recently
is has been discovered that bioflavonoids (including those from
green tea) could inhibit the activity of bacterial ATP synthase,
reducing the ability of the microorganisms to produce enough
energy (Chinnam et al., 2010).
OTHER INHIBITORY EFFECTS
Researchers have found that green tea catechins have inhibitory
effects on many other bacterial functions. One such effect
is inhibiting synthesis of PBP2′ in methicillin-resistant
KEY CONCEPT 3 | Resistant
Microorganisms have a variety of methods that they use to overcome antimi-
crobial agents (antimicrobial-resistance). There are four main mechanisms
that are used: inhibiting uptake of a drug, increased excretion of a drug
(e.g., efflux pumps), structural or functional modification of the microorgan-
ism drug target, or inactivating the drug directly. This antimicrobial-resistance
may be acquired from another similar organism, or a result of a mutation in
one or more of the microorganism’s own genes.
Staphylococcus aureus (MRSA) This inhibition leads to reversal
KEY CONCEPT 4 | MRSA
Methicillin-resistant Staphylococcus aureus (MRSA) have acquired a gene
that allows production of an altered penicillin-binding protein (PBP), PBP2′.
PBPs are transpeptidases that are used in the synthesis of the peptidogly-
can layer of the bacterial cell wall. PBP2′ has a greatly reduced affinity for
most of the β-lactam drugs, making these drugs ineffective against MRSA.
This makes the treatment of infections with MRSA much more difficult and
costly.
of resistance to β-lactam drugs (Yam et al., 1998). Another
effect on bacteria is the inhibition by green tea catechins on the
conjugative transfer of the R plasmid in Escherichia coli (Zhao
et al., 2001a). This could lead to decreased sharing of antimi-
crobial genes between bacteria. Research on staphylococci has
shown the ability of green tea catechins to inhibit the activity of
efflux pumps. In this particular study the efflux pump was Tet(K)
which is involved in resistance to tetracycline (Sudano Roccaro
et al., 2004). This same type of activity could very well-occur with
other efflux pumps, which could enhance the ability of certain
drugs to have an antimicrobial effect. A study performed with
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Helicobacter pylori found that green tea catechins blocked the abil-
ity of the bacteria to bind to the toll-like receptor-4 (TLR-4) on
gastric epithelial cells (Lee et al., 2004). This would lead to a dras-
tic reduction in that organism’s ability to cause gastric disease.
There are also inhibitory effects found with viruses. Research with
HIV-1 has shown that green tea EGCG binds to the CD4 T-cell
receptor, blocking the binding of the virus. This ability to block
viral cell binding has been proposed for use in therapy for HIV-1
infection (Williamson et al., 2006).
SYNERGY OF GREEN TEA WITH ANTIMICROBIALS
Researchers have taken the concept of green tea catechins as hav-
ing antimicrobial effects and expanded on this by performing
studies that would determine if the green tea catechins might
work synergistically with known antimicrobial agents. Many of
these studies have focused on Staphylococcus aureus (particularly
MRSA), Staphylococcus epidermidis, and Escherichia coli, among
others. Examples of those studies have found that green tea cate-
chins work synergistically with tetracycline against S. aureus and
S. epidermidis (Sudano Roccaro et al., 2004; Fanaki et al., 2008);
with penicillin against S. epidermidis (Haghjoo et al., 2013); with
penicillin, oxacillin, ampicillin/sulbactam, and imipenem against
MRSA (Hu et al., 2001, 2002; Zhao et al., 2001b; Stapleton
et al., 2006; Aboulmagd et al., 2011); and with chlorampheni-
col, ciprofloxacin, and cefotaxime against isolates of E. coli having
various levels of resistance, including extended-spectrum beta-
lactamase (ESBL) producers (Fanaki et al., 2008; Cui et al., 2012a;
Passat, 2012).
KEY CONCEPT 5 | ESBL
Extended-spectrum β-lactamase (ESBL) producing organisms are most
often members of the gram negative Enterobacteriaceae family. Beta-
lactamases are enzymes produced by the organism that are able to
hydrolyze β-lactam drugs, rendering these drugs inactive. Like MRSA, the
ESBLs have an increased resistance to penicillins and cephalosporins, but
are sensitive to carbapenems and β-lactamase inhibitors (drugs that inhibit
the activity of β-lactamases and are used together with a β-lactam drug,
such as ampicillin/sulbactam). Many ESBL producers are also multidrug-
resistant organisms (MRSOs), making treatment of these infections very
difficult.
GREEN TEA CATECHINS ANTIMICROBIAL SCOPE
A large variety of research has been performed assessing whether
or not green tea has antimicrobial activities. A summary of exam-
ples of this research is included in Table 2. The research results
shown do suggest that green tea may be effective against many
organisms. The research is pretty well-balanced between gram
positive and gram negative organisms, with a few viruses, fungi
and a parasite also represented. The main gram positive organism
represented is S. aureus. That is not surprising considering the
ongoing menace of MRSA. The most commonly studied gram
negative organism is E. coli. These results represent potentially
useful information for battling the emerging threat of ESBL and
Carbapenem-resistant Enterobacteriaceae (CRE) organisms. In a
previous study, green tea extract was shown to be effective against
E. coli strains isolated from UTIs. Many of these isolates (59/80)
were multi-drug resistant (MDROs), and six of the strains were
ESBLs (Reygaert and Jusufi, 2013). The results shown in Table 2,
along with the possible synergistic activities mentioned earlier,
suggest that green tea could be extremely useful as an antimicro-
bial agent. There are certain things to keep in mind when viewing
the results in Table 2. First, is the type of green tea and the prepa-
ration used. The research may have used green tea from various
locations around the globe. For the experiments, the preparation
may have included freshly brewed green tea, green tea extracts
(water, alcohol), or purified extracts of certain of the green tea
catechins. There are also various other factors that may affect
the composition of the tea (refer to the section on green tea
composition). The second thing to pay attention to is the type
of result reported. There are four basic types of results shown:
growth in colony-forming units (CFUs), or plaque-forming units
(PFUs) for viruses; minimal inhibitory concentration (MIC); the
size of zones of inhibition; and the optical density (O.D.) of
growth in liquid cultures. The percentage of increase or decrease
of any of these parameters may also be shown. In addition, for
viruses, other growth or detection measures made be shown.
Overall, the results indicate that green tea has great potential as
an antimicrobial agent.
KEY CONCEPT 6 | CRE
Carbapenem-resistant Enterobacteriaceae (CREs) are similar to ESBLs.
These organisms are resistant to all β-lactam drugs, and are not inactivated
by β-lactamase inhibitors. The most common ESBL-producing organisms are
Escherichia coli and Klebsiella pneumoniae. Treatment options are extremely
limited for infections involving these organisms.
DISCUSSION
The data discussed shows that green tea catechins EGCG and EGC
are bioavailable in plasma (both) and urine (EGC only) at poten-
tially therapeutic levels and in a timely manner (see Table 1).
Antimicrobial studies using various green tea extracts have shown
that there is a huge potential for the use of green tea in antimicro-
bial therapy (see Table 2). In a previous study, the amount of EGC
from brewed Japanese green tea excreted in the urine was calcu-
lated to be approximately 3.5mg per cup of tea. Since the results
of the study showed that most of the bacterial strains tested were
susceptible to EGC levels of ≤0.72mg, one cup of tea should be
able to control growth of the bacteria for up to 6 h or even longer
(Reygaert and Jusufi, 2013).
While the research results that have been discussed suggest that
green tea may be effective against many organisms, there are cer-
tain issues that need to be addressed concerning these results.
The first issue is how the results are displayed. The difficulty of
assessing these types of results, and how these results relate to
each other among the different research groups, can be confus-
ing. This brings us to the second major issue. Various agencies,
such as the Clinical and Laboratories Standards Institute (CLSI)
in the United States, have strict protocols for the determination
of antimicrobial susceptibility. Most of the research results that
have been performed using green tea have not necessarily fol-
lowed any of these types of guidelines. Therefore, the results of
these experiments may differ from what the results would have
been if strict protocols had been used. In the future, it will bemost
helpful if researchers would take the time to use these protocols.
That will make comparing the results, and assessing if the results
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Table 2 | Antimicrobial activity of green tea.
Source Organisms studied Antimicrobial activity References
Water extraction MRSA MIC as low as 0.78mg/ml Aboulmagd et al., 2011
Methanol extraction Enterococcus faecalis MIC 15.63μg/ml Aman et al., 2013
Water/ethyl acetate extraction Actinomyces
actinomycetemcomitans
Porphyromonas gingivalis
Prevotella intermedia
Streptococcus mutans
MIC 6.25mg/ml
MIC 12.5mg/ml
MIC 12.5mg/ml
MIC 2.58-3.98mg/ml
Araghizadeh et al., 2013
Methanol extraction Escherichia coli
E. faecalis
Salmonella typhi
Staphylococcus aureus
MIC 0.8mg/ml
MIC 1.6mg/ml
MIC 1.2mg/ml
MIC 0.8mg/ml
Archana and Abraham, 2011
Alcohol extraction E. coli
S. aureus
Vibrio cholerae
MIC most ≤20μg/ml
MIC most ≤20μg/ml
MIC most ≤30μg/ml
Bandyopadhyay et al., 2005
Standardized water extract MRSA MICs of 30 strains
50–180μg/ml
Cho et al., 2008
Pure EGCG E. coli
Pseudomonas aeruginosa
S. aureus
S. mutans
MIC 500mg/ml
MIC 500mg/ml
MIC 100mg/ml
MIC 100mg/ml
Cui et al., 2012b
Pure EGCG (Vero cells) HSV-1 12× ↓ PFUs 50μM de Oliveira et al., 2013
Water extraction E. coli 3× ↓ CFUs 10mg/ml Fanaki et al., 2008
Pure EGCG 50μM HIV-1 (infected lymphocytes) No p24 core antigen detected Fassina et al., 2002
Pure EGCG 10μM Hepatitis C virus (Huh 7.5.1 cells) CPE reduced by 90% Fukazawa et al., 2012
Pure EGCG Stenotrophomonas maltophilia
(40 isolates)
MIC ≤256mg/ml Gordon and Wareham, 2010
Pure EGCG Candida albicans MIC of 90% ≤250 mg/L Hirasawa and Takada, 2004
Catechin mixture P. gingivalis MIC 1.0mg/ml Hirasawa et al., 2002
Water extraction 50mg/ml Proteus mirabilis
Streptococcus pyogenes
Zone 21.8mm
Zone 17.3mm
Kim et al., 2008
Pure EGCG 50mg/ml Proteus mirabilis
Streptococcus pyogenes
Zone 24.2mm
Zone 19.0mm
Kim et al., 2008
Pure EGCG 200μM Listeria monocytogenes Decreased intracellular growth
106 → 102 CFUs
Kohda et al., 2008
Water extraction (in watermelon
juice) to 0 CFUs
E. coli
L. monocytogenes
S. aureus
Salmonella typhimurium
250mg/ml at 6 days
100mg/ml at 4 days
75mg/ml at 3 days
175mg/ml at 5 days
Kristanti and Punbusayakul, 2009
Ethanol extract 4.5mg E. coli
P. aeruginosa
S. aureus
Zone 13mm
Zone 10mm
Zone 12mm
Kumar et al., 2012
Ground tea leaves 1% wt/vol Bacillus cereus 24% ↓ CFUs at 24 h Lee et al., 2009
Water extraction
Methanol extraction
L. monocytogenes MIC 0.68mg/ml
MIC 0.26mg/ml
Mbata et al., 2008
Methanol extraction S. mutans MIC 100mg/ml Naderi et al., 2011
Pure EGCG Acinetobacter baumannii 50% MIC 0.312mg/ml
90% MIC 0.625mg/ml
Osterburg et al., 2009
Water extraction 2mg/ml Trypanosoma cruzi (in mouse
blood)
905 of organisms lysed Paveto et al., 2004
Water extraction MRSA
MDR P. aeruginosa
MIC 400μg/ml
MIC 800μg/ml
Radji et al., 2013
Water extraction Aspergillus niger
P. aeruginosa
S. aureus
MIC 50mg/ml
MIC 50mg/ml
MIC 50mg/ml
Rao et al., 2014
Standardized water extract E. coli (79 UPEC strains) MICs ≤2.5–4.0mg/ml Reygaert and Jusufi, 2013
(Continued)
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Table 2 | Continued
Source Organisms studied Antimicrobial activity References
Water extraction
Ethanol extraction
Pure EGCG
Influenza viruses H1N1
H3N2 (all in MDCK cells)
H5N2
0 PFUs at 500μg/ml
0 PFUs at 500μg/ml
0 PFUs at 500μg/ml
Shin et al., 2012
Pure EGCG 12.5μg/ml MRSA Oxacillin MIC reduced to 1μg/ml Stapleton et al., 2006
Water extraction 50μg/ml Influenza viruses H1N1
H3N2 (all in MDCK cells)
Influenza B
PFUs ↓ 100%
PFUs ↓ 90%
PFUs ↓ 95%
Song et al., 2005
Ethanol extract 9.375mg Helicobacter pylori Zone 7.5mm Stoicov et al., 2009
Standardized green tea extract
40μg/ml
Hepatitis B virus (in HepG2-N10
cells)
99% ↓ HBsAg
93% ↓ HBeAg
Xu et al., 2008
Water extraction S. aureus
S. epidermidis
Yersinia enterocolitica
MIC 0.28mg/ml
MIC 0.41mg/ml
MIC 0.41mg/ml
Yam et al., 1997
Pure EGCG 100μg/ml MRSA
MSSA
S. epidermidis
O.D. ↓ 0
O.D. ↓ 0
O.D. ↓ 0
Zhao et al., 2001b
are meaningful so much easier. In addition (and most impor-
tantly), in order for the results to be able to be translated into
clinical use, the protocols will need to be followed. That hav-
ing been addressed, it is still very encouraging to look at the
research performed and see that green tea could very possibly
be an effective antimicrobial agent, especially against multidrug-
resistant strains, and in particular, MRSA and ESBL producing
organisms. Hopefully, in the future, researchers will be able to
study the effects of green tea on infections in humans. This type
of research is a critical part of determining the antimicrobial
capabilities of green tea. It might possibly be incorporated into
research with other antimicrobial compounds. Perhaps naturo-
pathic practitioners could begin to collect data on patients using
green tea. With emerging multidrug-resistant organisms and the
lack of effective new antimicrobial drugs being produced, we
cannot afford to ignore the potential of green tea.
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